Codon AG - Akt. nach Kapitalher

CHIX:CNWKd (Germany)   Akt. nach Kapitalherabsetzung
€ 2.42 (0%) May 16
At Loss
Market Cap:
€ 4.01M ($ 4.35M)
Enterprise V:
€ 3.72M ($ 4.03M)
Volume:
-
Avg Vol (2M):
-
Also Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Codon AG ( ) from 2015 to May 24 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Codon AG stock (CHIX:CNWKd) PE ratio as of May 24 2024 is 0. More Details

Codon AG (CHIX:CNWKd) PE Ratio (TTM) Chart

To

Codon AG (CHIX:CNWKd) PE Ratio (TTM) Historical Data

Total 1013
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 12
Codon AG PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-24 At Loss 2023-03-15 At Loss
2023-05-16 At Loss 2023-03-14 At Loss
2023-05-15 At Loss 2023-03-13 At Loss
2023-05-12 At Loss 2023-03-10 At Loss
2023-05-11 At Loss 2023-03-09 At Loss
2023-05-10 At Loss 2023-03-08 At Loss
2023-05-09 At Loss 2023-03-07 At Loss
2023-05-08 At Loss 2023-03-06 At Loss
2023-05-05 At Loss 2023-03-03 At Loss
2023-05-04 At Loss 2023-03-02 At Loss
2023-05-03 At Loss 2023-03-01 At Loss
2023-05-02 At Loss 2023-02-28 At Loss
2023-05-01 At Loss 2023-02-27 At Loss
2023-04-28 At Loss 2023-02-24 At Loss
2023-04-27 At Loss 2023-02-23 At Loss
2023-04-26 At Loss 2023-02-22 At Loss
2023-04-25 At Loss 2023-02-21 At Loss
2023-04-24 At Loss 2023-02-20 At Loss
2023-04-21 At Loss 2023-02-17 At Loss
2023-04-20 At Loss 2023-02-16 At Loss
2023-04-19 At Loss 2023-02-15 At Loss
2023-04-18 At Loss 2023-02-14 At Loss
2023-04-17 At Loss 2023-02-13 At Loss
2023-04-14 At Loss 2023-02-10 At Loss
2023-04-13 At Loss 2023-02-09 At Loss
2023-04-12 At Loss 2023-02-08 At Loss
2023-04-11 At Loss 2023-02-07 At Loss
2023-04-10 At Loss 2023-02-06 At Loss
2023-04-07 At Loss 2023-02-03 At Loss
2023-04-06 At Loss 2023-02-02 At Loss
2023-04-05 At Loss 2023-02-01 At Loss
2023-04-04 At Loss 2023-01-31 At Loss
2023-04-03 At Loss 2023-01-30 At Loss
2023-03-31 At Loss 2023-01-27 At Loss
2023-03-30 At Loss 2023-01-26 At Loss
2023-03-29 At Loss 2023-01-25 At Loss
2023-03-28 At Loss 2023-01-24 At Loss
2023-03-27 At Loss 2023-01-23 At Loss
2023-03-24 At Loss 2023-01-20 At Loss
2023-03-23 At Loss 2023-01-19 At Loss
2023-03-22 At Loss 2023-01-18 At Loss
2023-03-21 At Loss 2023-01-17 At Loss
2023-03-20 At Loss 2023-01-16 At Loss
2023-03-17 At Loss 2023-01-13 At Loss
2023-03-16 At Loss 2023-01-12 At Loss

Codon AG (CHIX:CNWKd) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Codon AG

ISIN : DE000A3E5C08

Share Class Description:

CHIX:CNWKd: Akt. nach Kapitalherabsetzung
Description
Codon AG develops, produces and distributes autologous cell therapies for the minimally invasive repair of cartilage defects. The product being marketed is a cell therapy product for the minimally invasive treatment of cartilage damage in the knee joint that uses only the patient's own cartilage cells (autologous chondrocytes). CODON's method is currently used in over 200 clinics in Germany and more than 14,000 patients have already been treated.